荷兰生物科技公司Cradle近日宣布，已筹集2400万美元的A轮融资，使其总融资额达到3300万美元。该公司利用生成式人工智能技术帮助科学家设计和工程蛋白质，构建易于使用的基于网络的软件，任何科学家和实验人员团队都可以使用该软件，而无需生物信息学家或机器学习工程师的帮助。
Cradle的技术可大大提高蛋白质工程的研究效率和实验效果。通过生成式AI技术，Cradle可以生成各种蛋白质结构，并帮助科学家进行蛋白质结构和性质的预测和优化。此外，Cradle还构建了一个基于网络的软件平台，使得科学家和实验人员可以方便地共享和交流实验数据和结果，从而促进了科研合作的发展。
此次融资将主要用于继续开发和完善Cradle的技术，加速其商业化进程，并拓展其国际市场。Cradle的创始人兼CEO表示：“我们将继续致力于推动生物科技领域的发展，为科学家和实验人员提供更高效、更方便的蛋白质工程解决方案。”
新闻翻译（英文）：
Dutch biotech startup Cradle has announced a 24-million-dollar A-round financing, bringing its total funding to 33 million dollars. The company uses generative AI technology to assist scientists in designing and engineering proteins, and constructs an easy-to-use network-based software platform that any scientist and experimental team can use without needing the help of a bioinformaticist or machine learning engineer.
Cradle’s technology can significantly improve the research efficiency and experimental results of protein engineering. By using generative AI technology, Cradle can generate various protein structures and help scientists predict and optimize protein structure and properties. Additionally, the company has built a network-based software platform that enables scientists and experimentalists to share and communicate experimental data and results easily, promoting collaboration in the scientific community.
The financing will be used to further develop and commercialize Cradle’s technology, accelerate its commercialization process, and expand its international market. Cradle’s founder and CEO said, “We will continue to drive the development of biotechnology in the field, providing more efficient and convenient protein engineering solutions to scientists and experimentalists.”
【来源】https://tech.eu/2023/11/28/cradle-raises-24m-to-expand-generative-ai-for-protein-design-and-engineering/
Views: 1